Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR

Clinical trial NCT01880840 · COMPLETED

Trial details

NCT number: NCT01880840
Sponsor: Meda Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2013-06-01
Primary completion: 2014-04-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.